Newton vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI phone platform for dental practices handling patient scheduling, insurance verification, and reactivation campaigns; $3.8M seed from YC serving DSOs competing with Weave and NexHealth.
About
Newton is an AI-powered phone and patient communication platform for dental practices and dental service organizations (DSOs) — deploying AI voice agents that handle inbound patient calls (appointment scheduling, insurance verification questions, appointment reminders) and outbound patient reactivation campaigns that identify and contact overdue patients, automating the front-desk phone work that consumes significant staff time at dental offices. Founded in 2023 in San Francisco and a Y Combinator W24 graduate, Newton raised $3.8 million in seed funding in October 2025 from Y Combinator, Twenty Two Ventures, Transpose Platform, and Phosphor Capital.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.